Stop parsing PDFs. Get the API. Request Access

AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

KYUNG NAM PHARM.CO.,LTD.

Share Issue/Capital Change • May 21, 2019

16308_rns_2019-05-21_e39ea2af-cbee-4373-a66b-b9f77cb46f61.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

경남제약/증권 발행결과(자율공시)/(2019.05.21)증권 발행결과(자율공시)(제3자배정 유상증자)

증권 발행결과(자율공시)
1. 증권의 종류 보통주식
2. 발행방법 제3자배정 유상증자
3. 발행내역 발행예정주식수(주) 713,501
발행예정금액(원) 6,499,994,110
발행결정 최초 이사회결의일 2018-11-14
실제발행주식수(주) 713,501
실제발행금액(원) 6,499,994,110
납입일 2019-05-21
4. 상장예정 여부 예
5. 기타 투자판단에 참고할 사항 -
※관련공시 2019-05-15 유상증자결정(제3자배정)

More from KYUNG NAM PHARM.CO.,LTD.

Share Issue/Capital Change 2025
Sep 10
Major Shareholding Notification 2025
Aug 22
Interim / Quarterly Report 2025
Aug 14
Share Issue/Capital Change 2025
Aug 11
Share Issue/Capital Change 2025
Jul 10
Major Shareholding Notification 2025
Jun 27
Share Issue/Capital Change 2025
Jun 23
Share Issue/Capital Change 2025
Jun 10
Major Shareholding Notification 2025
May 21
Quarterly Report 2025
May 15
View all filings →

Talk to a Data Expert

Have a question? We'll get back to you promptly.